Immunodeficiency and tuberculosis;Dépression immunitaire et tuberculose

Revue du Praticien

Volumn 52, Issue 19, 2002, Pages 2139-2143

  Billy, Christophe ^a   Perronne, Christian ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPRENAVIR; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BCG VACCINE; CD4 ANTIGEN; CYTOCHROME P450; DELAVIRDINE; EFAVIRENZ; ETHAMBUTOL; INDINAVIR; ISONIAZID; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BCG VACCINATION; COMORBIDITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG METABOLISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LEUKOCYTE COUNT; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; TUBERCULOSIS; VIRUS INFECTION;

HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; RISK FACTORS; TUBERCULOSIS;

EID: 0036899093     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Ellner JJ. The immune response in human tuberculosis: Implications for tuberculosis control. J Infect Dis 1997; 176: 1351-9.
2. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941-9.
3. Barnes PF, Modlin RL. Human cellular immune responses to Mycobacterium tuberculosis. Curr Top Microbiol Immunol 1996; 215: 197-219.
4. Nakata K, Rom WN, Honda Y et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997; 155: 996-1003.
5. Raviglione MC, Narain JP, Kochl A. HIV-associated tuberculosis in developing countries: Clinical features, diagnosis, and treatment. BullWorld Health Organ 1992; 70: 515-26.
6. Decludt B, Campese C, Institut de veille sanitaire. Les cas de tuberculose déclarés en France en 2000. Bull Epidemiol Hebd 2002;16-17:68-70.
7. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic. JAMA 1995; 275: 220-6.
8. Bates JH, Stead WW. The history of tuberculosis as a global epidemic. Med Clin North Am 1993; 77: 1205-17.
9. Selwyn PA, Hartel D, Lewis VA et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-50.
10. Daley CL, Small PM, Schecter GF. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 36: 231-5.
11. Small PM, Shafer RW, Hopewell PC et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328: 1137-44.
12. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1998; 340: 367-73.
13. Alland D, Kalbut GE, Moss AR et al. Transmission of tuberculosis in New York City: An analysis of DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710.
14. Centers for Disease Control and Prevention. Prevention of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998; 47: 1-58.
15. Jones BE, Ryu R, Yang Z et al. Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med 1997; 156: 1270-3.
16. Centers for Diseases Control and Prevention. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991; 40: 585-91.
17. American Thoracic Society. Rapid diagnostic test for tuberculosis: What is the appropriate use? Am J Respir Crit Care Med 1997; 155: 1804-14.
18. Pulido F, Pena JM, Rubio R et al. Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Arch Intern Med 1997; 157: 227-32.
19. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157-61.
20. Gordin FM, Matts JP, Miller C et al. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. N Engl J Med 1997; 337: 315-20.
21. Whalen CC, Johnson JL, Okwera A et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801-8.
22. Perronne C. Tuberculosis, HIV infection, and malnutrition: An infernal trio in central Africa. Nutrition 1999; 15: 321-2.
23. Dummer JS, Ho M. Risk factors and approaches to infections in transplant recipients. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Disease. New York: John Willey & Sons, 2000: 3126-36.